Matthew L. Sherman is VP at ACCELERON PHARMA INC (XLRN). They have made 20 open-market trades across 2 companies since 2014, most recently 2024-06-11.
CIK 0001325710
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases since 2018, against 20 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DCPH | SELL | 2024-02-16 | 2024-02-20 | $15.62 | $41K | +12.9% | +0.8% | +65.6% |
| DCPH | SELL | 2024-01-16 | 2024-01-18 | $14.47 | $35K | +3.2% | +12.0% | +6.0% |
| DCPH | SELL | 2023-12-13 | 2023-12-14 | $15.37 | $43K | -0.1% | -10.0% | -0.5% |
| DCPH | SELL | 2023-10-30 | 2023-10-31 | $12.02 | $28K | -4.1% | +5.1% | +24.6% |
| DCPH | SELL | 2023-10-02 | 2023-10-04 | $12.68 | $37K | -12.0% | -1.2% | +34.6% |
| DCPH | SELL | 2023-06-16 | 2023-06-21 | $14.40 | $24K | -5.2% | -7.4% | -5.4% |
| DCPH | SELL | 2023-02-16 | 2023-02-17 | $15.10 | $15K | -0.3% | +6.5% | -4.8% |
| DCPH | SELL | 2023-01-17 | 2023-01-19 | $21.24 | $102K | -14.6% | -27.1% | -22.9% |
| DCPH | SELL | 2022-10-03 | 2022-10-05 | $18.73 | $48K | -8.0% | -15.1% | -14.9% |
| DCPH | SELL | 2022-06-16 | 2022-06-21 | $10.75 | $19K | +9.9% | +12.0% | +54.2% |
| DCPH | SELL | 2022-02-16 | 2022-02-18 | $9.05 | $9K | -5.9% | +12.1% | +43.7% |
| DCPH | SELL | 2021-10-04 | 2021-10-06 | $33.17 | $176K | +9.5% | -71.5% | -65.6% |
| DCPH | SELL | 2021-02-16 | 2021-02-18 | $48.87 | $6K | -2.4% | +0.2% | -27.5% |
| XLRN | SELL | 2018-04-03 | 2018-04-04 | $38.43 | $177K | -2.3% | -6.2% | +22.7% |
| XLRN | SELL | 2018-01-03 | 2018-01-04 | $42.90 | $286K | +4.6% | -9.5% | -10.8% |
| XLRN | SELL | 2017-09-12 | 2017-09-14 | $38.41 | $707K | -11.5% | -4.2% | -5.1% |
| XLRN | SELL | 2017-07-05 | 2017-07-07 | $32.00 | $512K | -5.2% | +8.5% | +17.8% |
| XLRN | SELL · 10b5-1 | 2017-01-04 | 2017-01-06 | $27.46 | $55K | -9.2% | -11.0% | -3.4% |
| XLRN | SELL | 2016-07-01 | 2016-07-06 | $34.74 | $903K | -6.1% | -4.7% | +2.1% |
| XLRN | SELL | 2016-07-01 | 2016-07-06 | $34.74 | $903K | -6.1% | -4.7% | +2.1% |
| XLRN | SELL | 2016-04-06 | 2016-04-08 | $32.00 | $832K | -3.2% | -2.1% | +7.8% |
| XLRN | SELL · 10b5-1 | 2015-10-15 | 2015-10-16 | $23.28 | $140K | -30.5% | -6.3% | -27.0% |
| XLRN | SELL · 10b5-1 | 2015-09-16 | 2015-09-18 | $33.24 | $66K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-08-18 | 2015-08-19 | $31.11 | $212K | -30.5% | -6.3% | -6.3% |
| XLRN | SELL · 10b5-1 | 2015-07-20 | 2015-07-21 | $32.46 | $195K | -30.5% | -6.3% | -6.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.